PharmTech News

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

Articles

Results of a Phase II clinical trial reveal that stem-cell transplantation treatment following complete immune system destruction increases the duration of long-term remission in patients with multiple sclerosis.

New Aggressive Treatment Shown to Halt Symptoms of Multiple Sclerosis for a Prolonged Period

An article in Nature Reviews Drug Delivery reports the clinical success rates of biologics, and these numbers differ from those recently highlighted in a similar BIO study.

Diverging Results in Clinical Success Rates for Biologics

New pharmacovigilance activities seek to support the creation of guidelines for safe switching from innovator products to biosimilars.

Dutch System to Track Biosimilar Use and Switching Announced

As the battle for ownership over the use of CRISPR to edit DNA heats up, some of the CRISPR pioneers refocus their efforts to demonstrate the technology’s applications for editing RNA.

Using a New CRISPR Effector to Edit RNA

Lagarde will be based out of the company’s Boston office and will lead Patheon’s global corporate and cross-enterprise operations.

Patheon Appoints Michel Lagarde President

In the largest-ever report of its kind, drugs entering clinical development in Phase I were found to have only a 1 in 10 chance of FDA approval.

Clinical Development Success Rates Examined in New BIO Report

Colorcon Acquired BASF’s Kollicoat IR Coating System product line, which includes currently customer business, and inventory.

Colorcon Acquires BASF’s Kollicoat IR Coating Systems

FDA accepted for review Samsung Bioepis’ BLA for SB2, a biosimilar to Remicade (infliximab).

FDA Accepts Samsung Bioepis' BLA for Remicade Biosimilar

The NIH and partners will launch a large-scale clinical trial in South Africa to evaluate the effectiveness of an HIV vaccine regimen

NIH to Launch Large-Scale HIV Vaccine Trial

Pfizer will acquire Anacor for $5.2 billion and expects the transaction to complete in the third-quarter of 2016.

Top News